Evidence map›Paper›PMID 33325804›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2021

Profibrotic epithelial TGF-β1 signaling involves NOX4-mitochondria cross talk and redox-mediated activation of the tyrosine kinase FYN.

Carmen Veith, Milena Hristova, Karamatullah Danyal, Aida Habibovic, Christopher M Dustin, John E McDonough, Bart M Vanaudenaerde, Michael Kreuter, Marc A Schneider, Nicolas Kahn and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. AlClBioFactors (Oxford, England)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Carmen VeithDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont.
Milena HristovaDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont.
Karamatullah DanyalDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont.
Aida HabibovicDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont.
Christopher M DustinDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont.
John E McDonoughLaboratory of Respiratory Diseases, Department of Chronic Diseases, Metabolism, and Ageing, KU Leuven, Leuven, Belgium.
Bart M VanaudenaerdeLaboratory of Respiratory Diseases, Department of Chronic Diseases, Metabolism, and Ageing, KU Leuven, Leuven, Belgium.
Michael KreuterCenter for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany.
Marc A SchneiderTranslational Research Unit, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany.
Nicolas KahnCenter for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany.
Frederik J van SchootenDepartment of Pharmacology and Toxicology, NUTRIM School of Nutrition, Translational Research and Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Agnes W BootsDepartment of Pharmacology and Toxicology, NUTRIM School of Nutrition, Translational Research and Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Albert van der VlietDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont.ORCID 0000-0003-0923-0016
University of Vermont · USHeidelberg University · DEKU Leuven · BEMaastricht University · NL

Funding

Dual Oxidase in Airway Epithelial Repair and RemodelingR01HL085646 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2008 to 2020
$4.7M
DUOX1 and Mitochondria in Obese AsthmaR01HL138708 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2017 to 2020
$2.1M
INVERTED LASER-SCANNING CONFOCAL MICROSCOPE: LUNG RESEARCHS10RR019246 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TAATJES, DOUGLAS J. · 2004 to 2004
$473k
DUOX1 Silencing in Age-Related COPDR21AG055325 · NIA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2017 to 2018
$429k
Redox Regulation of Src Kinase in Allergic Airway InflammationF31HL142221 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI DUSTIN, CHRISTOPHER MICHAEL · 2018 to 2019
$62k
HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) HL085646HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) HL138708HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) HL142221HHS | NIH | National Institute on Aging (U.S. National Institute on Aging) AG055325NCRR NIH HHS S10 RR019246NHLBI NIH HHS F31 HL142221NHLBI NIH HHS R01 HL085646NHLBI NIH HHS R01 HL138708NIA NIH HHS R21 AG055325
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterized by a disturbed redox balance and increased production of reactive oxygen species (ROS), which is believed to contribute to epithelial injury and fibrotic lung scarring. The main pulmonary sources of ROS include mitochondria and NADPH oxidases (NOXs), of which the NOX4 isoform has been implicated in IPF. Non-receptor SRC tyrosine kinases (SFK) are important for cellular homeostasis and are often dysregulated in lung diseases. SFK activation by the profibrotic transforming growth factor-β (TGF-β) is thought to contribute to pulmonary fibrosis, but the relevant SFK isoform and its relationship to NOX4 and/or mitochondrial ROS in the context of profibrotic TGF-β signaling is not known. Here, we demonstrate that TGF-β1 can rapidly activate the SRC kinase FYN in human bronchial epithelial cells, which subsequently induces mitochondrial ROS (mtROS) production, genetic damage shown by the DNA damage marker γH2AX, and increased expression of profibrotic genes. Moreover, TGF-β1-induced activation of FYN involves initial activation of NOX4 and direct cysteine oxidation of FYN, and both FYN and mtROS contribute to TGF-β-induced induction of NOX4.

Indexed as

Signal TransductionBronchiEpithelial CellsHumansIdiopathic Pulmonary FibrosisMitochondriaNADPH Oxidase 4Oxidation-ReductionProto-Oncogene Proteins c-fynReactive Oxygen SpeciesTransforming Growth Factor beta1FYN protein, humanNADPH Oxidase 4NOX4 protein, humanProto-Oncogene Proteins c-fynReactive Oxygen SpeciesTGFB1 protein, humanTransforming Growth Factor beta1idiopathic pulmonary fibrosismitochondriaNOX4redox signalingSRC

Identifiers

PMID33325804
PMCPMC8354818
OpenAlexW3113212999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.